Christensen, E.; Foss, O.A.; Quist-Paulsen, P.; Staur, I.; Pettersen, F.; Holien, T.; Juzenas, P.; Peng, Q.
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study. Pharmaceutics 2021, 13, 1558.
https://doi.org/10.3390/pharmaceutics13101558
AMA Style
Christensen E, Foss OA, Quist-Paulsen P, Staur I, Pettersen F, Holien T, Juzenas P, Peng Q.
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study. Pharmaceutics. 2021; 13(10):1558.
https://doi.org/10.3390/pharmaceutics13101558
Chicago/Turabian Style
Christensen, Eidi, Olav A. Foss, Petter Quist-Paulsen, Ingrid Staur, Frode Pettersen, Toril Holien, Petras Juzenas, and Qian Peng.
2021. "Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study" Pharmaceutics 13, no. 10: 1558.
https://doi.org/10.3390/pharmaceutics13101558
APA Style
Christensen, E., Foss, O. A., Quist-Paulsen, P., Staur, I., Pettersen, F., Holien, T., Juzenas, P., & Peng, Q.
(2021). Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study. Pharmaceutics, 13(10), 1558.
https://doi.org/10.3390/pharmaceutics13101558